Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-09-24 | Rezolute, Inc. | Hogenhuis Wladimir
(Director) |
P | Common Stock | A | 4259 | $4.70 - $4.70 | $20,017 |
2024-06-25 | Rezolute, Inc. | Hogenhuis Wladimir
(Director) |
P | Common Stock | A | 4815 | $4.15 - $4.15 | $19,982 |
2024-06-14 | Rezolute, Inc. | ROBERTS BRIAN KEN...
(Chief Medical Officer) |
P | Common Shares | A | 7600 | $3.91 - $3.97 | $29,741 |
2024-06-14 | Rezolute, Inc. | Evans Daron
(CFO) |
P | Common Shares | A | 40000 | $4.04 - $4.04 | $161,568 |
2024-05-23 | Rezolute, Inc. | ROBERTS BRIAN KEN...
(Chief Medical Officer) |
P | Common Shares | A | 7500 | $2.68 - $2.72 | $20,137 |
2024-05-23 | Rezolute, Inc. | Evans Daron
(CFO) |
P | Common Shares | A | 3000 | $2.85 - $3.23 | $9,667 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |